Immune Pharma raises $18M in follow-on

On Oct. 19, immunology and inflammation company Immune Pharmaceuticals Inc. (NASDAQ:IMNP; SSE:IMNP) raised $18 million through the sale of 18,000 units at $1,000 in a follow-on underwritten by Maxim Group...